Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Virax Biolabs Group Limited - Ordinary Shares (NQ:VRAX)

0.2284 +0.0659 (+40.55%)
Streaming Delayed Price Updated: 11:18 AM EDT, Mar 31, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Virax Biolabs Group Limited - Ordinary Shares

< Previous 1 2 3 4 5 6 7 Next >
The market is filled with gapping stocks in Tuesday's session. ↗
Via Chartmill
Discover the top movers in Tuesday's pre-market session. ↗
Via Chartmill
Get insights into the top gainers and losers of Wednesday's after-hours session. ↗
Via Chartmill
Wondering what's happening in today's after-hours session? ↗
Via Chartmill
News headline image
How Is The Market Feeling About Virax Biolabs Group? ↗
 
Via Benzinga
News headline image
Let's take a look at the stocks that are in motion in today's session. ↗
Looking for insights into the US markets in the middle of the day on Thursday? Delve into the top gainers and losers of today's session and gain valuable market intelligence. 
Via Chartmill
News headline image
What's going on in today's pre-market session ↗
Before the US market kicks off on Thursday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers. 
Via Chartmill
News headline image
Stay updated with the stocks that are on the move in today's after-hours session. ↗
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements. 
Via Chartmill
News headline image
Let's take a look at the stocks that are in motion in today's session. ↗
Here are the top movers in Wednesday's session, showcasing the stocks with significant price changes. 
Via Chartmill
News headline image
These stocks are the most active in today's session ↗
Get a pulse on the US markets on Wednesday by checking out the most active stocks in today's session. Discover the stocks that are leading the way in terms of trading volume and market activity. 
Via Chartmill
News headline image
These stocks are moving in today's session ↗
Looking for insights into the US markets in the middle of the day on Wednesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence. 
Via Chartmill
News headline image
Which stocks are gapping on Wednesday? ↗
The market is buzzing with gapping stocks on Wednesday. Let's uncover which stocks are experiencing notable gaps during today's session. 
Via Chartmill
News headline image
Get insights into the top gainers and losers of Wednesday's pre-market session. ↗
Discover the top movers in Wednesday's pre-market session and stay informed about market dynamics. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
EXCLUSIVE: Virax Biolabs Inks Research Pact To Advance Long COVID Diagnostic Studies ↗
Virax Biolabs partners with Emory University to study its T cell diagnostic ViraxImmune for long COVID, aiming for FDA guidance and U.S. market entry. 
Via Benzinga
News headline image
What's Driving the Market Sentiment Around Virax Biolabs Group? ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
 
Via Benzinga
News headline image
Virax Biolabs' Investigational Diagnostic Tests Has An Attractive Market Opportunity', Analyst Initiates With Buy Rating ↗
Virax Biolabs' T-cell testing platform targets post-viral syndromes like Long COVID. HC Wainwright sees a major market opportunity, setting a $3 price target. 
Via Benzinga
News headline image
EXCLUSIVE: Virax Biolabs Says Its Tech Fits RFK Jr.'s HHS Goals On Vaccine Transparency ↗
Virax Biolabs supports HHS's focus on vaccine efficacy transparency, offering technology to assess immune responses and collaborate with developers to improve vaccine research. 
Via Benzinga
News headline image
Why Sangamo Therapeutics Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Nasdaq Down 2%; US Crude Stocks Increase ↗
 
Via Benzinga
News headline image
Gold Moves Lower; AT&T Earnings Top Views ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
Dow Tumbles Over 250 Points; Boeing Posts Q3 Loss ↗
 
Via Benzinga
Topics Stocks
News headline image
EXCLUSIVE: Virax Biolabs Inks Distribution Pact To Commercialize ImmuneSelect Profiling Solutions In UK And Ireland ↗
Virax Biolabs partners with Europa Biosite to distribute ImmuneSelect for research use, focusing on T-cell immunity and post-viral syndromes, including Long COVID. 
Via Benzinga
News headline image
EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In August 2024 – Where Do Tesla, Nvidia, Apple, AMD Stock Rank? ↗
A look at the top 20 most-searched tickers on Benzinga Pro for the month of August. 
Via Benzinga
News headline image
Nasdaq Down Over 1%; Foot Locker Shares Tumble After Q2 Results ↗
 
Via Benzinga
News headline image
What's Going On With Virax Biolabs Stock Wednesday ↗
Virax Biolabs stock is trading higher on Wednesday after the company announced it entered into a distribution agreement with a supplier of RT-PCR Mpox detection kits. 
Via Benzinga
Topics Supply Chain
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS